Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis

Figure 1

Bhalla score and spirometry values in Cystic Fibrosis patients modulated by polymorphism in ADRB2 gene. Association of the cystic fibrosis severity with polymorphism Arg16Gly in ADRB2 gene. A. Bloxplot of the Bhalla score in patients with two identified mutations in CFTR gene. The Bhalla score data is a gross value. # p:0.011; * p:0.779; ¥ p:0.007. B. Bloxplot of FEV1(%) in patients without taking CFTR mutation into account. # p:0.007; * p:0.277; ¥ p:0.003. C. Bloxplot of FEF25-75% in patients without without taking CFTR mutation into account. # p:0.038; * p:0.43; ¥ p:0.015. D. Bloxplot of FEF25-75% in patients with no mutations identified in CFTR gene. # p:0.933; * p:0.008; ¥ p:0.001. The data of the spirometry are in percentage of the predicted population value. The test used for the analyses was the T´student test.

Back to article page